# Azurity Pharmaceuticals, Inc. – FDA Inspection, Mar 2, 2023

Source: https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/d81f0586-7c5d-4396-a80e-766283dec67c
Source feed: FDA_Inspections

> FDA inspection 1199279 of Azurity Pharmaceuticals, Inc., March 02, 2023. 5 citations under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199279
- Company Name: Azurity Pharmaceuticals, Inc.
- Inspection Date: 2023-03-02
- Project Area: Drug Quality Assurance
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 5

## Related Documents

- [FDA Inspection 1297348 - 2025-12-12](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/7c93bd99-060c-47b1-906c-ce6cdfe7bf52)
- [FDA Inspection 1261303 - 2025-02-19](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/5bc3e1cb-551b-4b19-8657-c5a1e0e2c087)
- [FDA Inspection 1163010 - 2022-02-24](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/12a62341-3a2c-4ccd-af8a-ac1ef6bbb9ad)
- FDA Inspection 1100022 - 2019-07-26
- FDA Inspection 1038444 - 2017-12-20

## Related Officers

- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)

Company: https://www.keypedia.com/companies/azurity-pharmaceuticals-inc/be6c2042-21df-4e44-a30d-11c6629303d8

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144